Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissue (Q39977436)

16 September 2017

Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissue (English)

1 reference

16 September 2017

L J Duerner

1

1 reference

16 September 2017

A Schwantes

2

1 reference

16 September 2017

I C Schneider

3

1 reference

16 September 2017

K Cichutek

4

1 reference

16 September 2017

C J Buchholz

5

1 reference

16 September 2017

29 May 2008

1 reference

16 September 2017

1 reference

16 September 2017

15

1 reference

16 September 2017

22

1 reference

16 September 2017

1500-1510

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2008.92

16 September 2017

0 references

cites work

Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Replicative retroviral vectors for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Tissue-specific transcriptional targeting of a replication-competent retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Focal cortical dysplasia: a review of pathological features, genetics, and surgical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Protease degradomics: a new challenge for proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

In vivo selection of protease cleavage sites from retrovirus display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Retroviral display and high throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Gene therapy for severe combined immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Occurrence of leukaemia following gene therapy of X-linked SCID.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Human and mouse proteases: a comparative genomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

inferred from DOI database lookup

7 January 2021

based on heuristic

Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

inferred from DOI database lookup

7 January 2021

based on heuristic

Elevated telomerase activity,c-MYC-, andhTERTmRNA expression: association with tumour progression in malignant lipomatous tumours

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.92

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2008.92

1 reference

16 September 2017

1 reference